AlphAIAlphAI — Financial news for AI agents
tipranks.comOCT 272 min read$CAH

Cardinal Health, McKesson awarded $2.7B and $741.5M DLA contracts respectively

Cardinal Health (CAH) and McKesson (MCK) won DLA contracts worth $2.7B and $741.5M respectively for medical surgical supplies. The contracts last until 2029 with option periods. Customers include military branches and health agencies. Defense working capital funds from 2027-2030 will finance the contracts.

Original reporting
tipranks.com
Published Oct 27, 2026, 9:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 11:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$CAH
Bullish
high confidence
Mentioned
$CAH · $MCK
Relevance
7/10
AlphAI data visualization · based on tipranks.com
Decision brief

The 30-second read

$CAHBullishMed
01

Why it matters

These contracts represent a multi‑year revenue boost for both companies, likely improving earnings forecasts and supporting share price appreciation.

02

Market read

First‑report contract awards to two large distributors; material dollar amounts; likely to influence stock pricing and sector sentiment.

03

What to watch

Potential delays in defense funding or supply‑chain bottlenecks may limit upside.

Relevance 7/10Novelty 9/10Timing: today

Background

The Defense Logistics Agency (DLA) awarded two indefinite‑delivery contracts to major U.S. distributors for medical‑surgical products, covering fiscal years 2027‑2030.

Company-level read

Ticker impact

$CAHBullishHigh confidence
Context

Cardinal Health was awarded a $2.7 billion fixed‑price DLA contract for medical‑surgical supplies.

Expected impact

likely upside as investors price in the new contract revenue

Evidence & confidence

Large, multi‑year defense contract; first disclosure; material to top‑line.

$MCKBullishHigh confidence
Context

McKesson secured a $741.5 million DLA contract for medical‑surgical supplies.

Expected impact

likely modest upside as market absorbs the new revenue source

Evidence & confidence

Significant contract size for a mid‑cap distributor; first report; material impact.

Market effects

Sector

Boosts outlook for the healthcare distribution and defense logistics sector.

Regional

Strengthens U.S. defense procurement spending outlook.

Global

Highlights continued demand for medical‑surgical supplies in global defense contracts.

Counterpoint

What could challenge this read

If execution costs exceed expectations, the contracts could pressure margins.

Key entities

  • company
    Cardinal Health

    U.S. healthcare services and products distributor (ticker CAH).

  • company
    McKesson

    U.S. pharmaceutical distribution giant (ticker MCK).

  • government_agency
    Defense Logistics Agency

    U.S. DOD agency responsible for logistics and procurement.

Read at source← All news

Related articles

OCT 27
$CAHHigh

Pentagon Awards Cardinal Health $1.5 Billion Contract

Cardinal Health won a $1.5 billion contract from the Pentagon for the Medical Surgical Prime Vendor program. The contract, awarded after competitive bidding, has a base period of two years and six months with three optional extensions. The ordering period ends on December 6, 2029, according to the Defense Department.

morningstar.com1 min
OCT 27
$MCKLow

Built and Bred

McKesson (MCK) will invest $179M in a 330,000 sq. ft. regional distribution center in Moore, Oklahoma, creating 200+ jobs. The site's location, readiness, and regional coordination influenced the decision, according to the company.

citylifestyle.com2 min
OCT 10
$OPCHHighAI 9/10

Option Care Health Sold for $5.8B in CD&R-McKesson Deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $5.8B, or $32.05 per share, a 37% premium. The deal, expected to close in 2027, values the company at $5.8B. Option Care Health will operate independently post-acquisition. The company reported $5.6B in 2025 revenue and $207.6M in net income, with modest growth in 2026. The acquisition aligns with McKesson's strategy to expand access to innovative therapies.

hoodline.com2 min
OCT 9
$MCKHighAI 9/10

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson (MCK) is acquiring Option Care Health (OPCH) for $5.8B, including debt, at $32.05 per share, a 37% premium. McKesson and private equity firm CD&R will own 49% and 51% respectively. The deal expands McKesson's specialty healthcare services. McKesson's Q1 2027 revenue was $105.4B, beating estimates, with adjusted EPS up 20% YoY to $9.93. The company raised its fiscal 2027 adjusted EPS guidance to $44.20-$45.00.

finance.yahoo.com2 min
OCT 8
$MCKHighAI 9/10

McKesson & CD&R Acquire Leading US Home-Infusion Platform

McKesson and private equity firm CD&R will acquire Option Care Health, a US home-infusion care provider, for $5.8bn. CD&R will take a majority stake, while McKesson invests $1.4bn for a minority stake. The deal values Option Care Health at $32.05 per share and is expected to close in H1 2027. McKesson aims to leverage the acquisition to expand its specialty care offerings.

healthcare-digital.com3 min
OCT 7
$OPCHHighAI 9/10

Option Care stock surges on McKesson's home-infusion bet

Option Care Health (OPCH) shares rose 33% to $31.11 after McKesson (MCK) and Clayton, Dubilier & Rice agreed to take it private for $32.05 per share, valuing it at $5.8B. McKesson will initially own 49%, with an option to acquire the rest later. The deal gives McKesson access to Option Care's home-infusion network, serving 315K+ patients. Option Care's Q2 revenue grew 1.9% to $1.44B. The deal needs shareholder and regulatory approvals to close in early 2027.

finance.yahoo.com2 min